Ecnoglutide

DB19019InvestigationalProtein Based Therapies

Ecnoglutide is under investigation in clinical trial NCT05813795 (A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity).

Mechanism: Pharmacologically active on Glucagon-like peptide 1 receptor
Curator reviewed
Code names: VRB-101 · XW-003 · XW004

Resolves to

Compound

UNIIKM6YM7L8LHCAS2459531-73-6

Targets

P43220GLP1R

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ecnoglutide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account